Benefit VA: Assessing the benefit of venetoclax addition in veterans with CLL/SLL responding to BTK inhibitor therapy
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Daphne Friedman, Solomon Graf, Gerald Hsu, Thomas Rodgers, Manali Patel, Jesse Troy, Murali Nittala, Kenute Myrie, Suman Kambhampati
Institutions: Duke University, Durham VA Health Care System, University of Washington, VA Puget Sound Health Care System, San Francisco VA Medical Center, University of California, San Francisco, VA Palo Alto Health Care System, Stanford University, Kansas City VA Medical Center, United States Department of Veterans Affairs, Veterans Health Administration, University of Kansas
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417004745
Cites:
Cited by:
Related to: